🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
This study will test a drug called enfortumab vedotin in participants with ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2021-12-07
Trial ID
NCT05014139
Treatments Being Tested
This prospective observational study aims to evaluate the correlation betwe...
Status
Not Yet Recruiting
Location
National Taiwan University Hospital
Start Date
2025-07
Trial ID
NCT07072637
Treatments Being Tested
The goal of this clinical trial is to learn if the timing of treatments pla...
Status
Not Yet Recruiting
Location
BC Cancer - Abbotsford
Start Date
2026-05
Trial ID
NCT07346053
Treatments Being Tested
The primary purpose of this study is to determine the antitumor activity of...
Status
Active Not Recruiting
Location
Arizona Oncology
Start Date
2020-03-10
Trial ID
NCT04225117
Treatments Being Tested
A Phase II Open-Label Study of Enfortumab Vedotin in Patients with Previous...
Status
Active Not Recruiting
Location
University of Kansas Cancer Center
Start Date
2023-06-30
Trial ID
NCT05915351
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of an ...
Status
Recruiting
Location
City of Hope
Start Date
2026-06
Trial ID
NCT07484022
Treatments Being Tested
People with a type of bladder cancer called muscle-invasive bladder cancer ...
Status
Recruiting
Location
Arkansas Urology Associates
Start Date
2026-03-12
Trial ID
NCT07475806
Treatments Being Tested
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
A study examining the safety of AGS-22M6E or ASG-22CE administered as monot...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2011-07-11
Trial ID
NCT01409135